A sensitive, competitive enzyme-linked immunosorbent assay (ELISA) for the detection of the antimicrobial triclosan (TCS; 2,4,4′-trichloro-2′-hydroxydiphenyl ether) was developed. Novel immunizing haptens were synthesized by derivatizing at the 4-Cl position of the TCS molecule. Compounds derived from substitutions at 4′-Cl and that replaced the 2′-OH with a Cl atom were designed as unique coating antigen haptens. Polyclonal rabbit antisera were screened against the coating antigen library to identify combinations of immunoreagents resulting in the most sensitive assays. The most sensitive assay identified was one utilizing antiserum no. 1155 and a heterologous competitive hapten, where the 2′-OH group was substituted with a Cl atom. An IC 50 value and the detection range for TCS in assay buffer were 1.19 and 0.21−6.71 μg/L, respectively. The assay was selective for TCS, providing low cross-reactivity (<5%) to the major metabolites of TCS and to brominated diphenyl ether-47. A second assay utilizing a competitive hapten containing Br instead of Cl substitutions was broadly selective for both brominated and chlorinated diphenylethers. Using the most sensitive assay combination, we measured TCS concentrations in water samples following dilution. Biosolid samples were analyzed following the dilution of a simple solvent extract. The immunoassay results were similar to those determined by LC−MS/MS. This immunoassay can be used as a rapid and convenient tool to screen for human and environmental exposure. Figure 1. Structures of immunizing and coating haptens. Arrows on the TCS structure indicate sites where the functional group was introduced. Haptens B1 and B2 were previously used for the development of a BDE-47 immunoassay.
■ INTRODUCTION
Triclosan (TCS; 2,4,4′-trichloro-2′-hydroxydiphenyl ether) is widely used as an antimicrobial agent in household and personal care products ( Figure 1 ). The widespread use of TCS has resulted in its presence in wastewater effluents, biosolids, and in surface receiving waters. 1−5 This results in direct exposure to aquatic animals, such as fish and snails. The land application of biosolids presents concerns about the potential for reentry of TCS into the environment and, therefore, additional exposure pathways. 6 Human and animal exposure to TCS is of great concern because it has been demonstrated to be an antagonist in both estrogen-mediated and androgenmediated bioassays and a potent Ca 2+ channel sensitizer and uncoupler in a ryanodine receptor-mediated bioassay and primary muscle cells, and it increases susceptibility to liver carcinogenesis. 7−10 Current analytical methods are based on LC−MS/MS, GC/ ECD, or GC/MS for the detection of TCS in wastewater and environmental samples. Analysis of water and biosolids typically includes sample preparation steps such as liquid−liquid and solid-phase extraction and, for GC analysis, derivatization of the hydroxyl group. 11−13 Although these methods are well-suited for their applications, for routine monitoring, a simple, robust, rapid method that can analyze a large number of samples is desired. Immunoassay methods can serve as a rapid screen for environmental contaminants, pesticides, and their degradation products in environmental chemistry. 14, 15 These techniques are widely used in diagnostics, environmental monitoring, food quality, agriculture, and field or on-site testing of personnel exposed to toxic chemicals. We have demonstrated these routine immunoanalytical techniques using environmental and biological samples such as house dust, soil, water, urine, and blood. 14, 16, 17 The objective of this study was to develop an enzyme-linked immunosorbent assay (ELISA) for the analysis of TCS as a simple monitoring tool. Our approach was 2-fold. First, novel immunizing and competitive haptens were carefully designed and synthesized. For immunizing, the design focused on haptens that most closely mimicked the target analyte for the development of selective antibodies. With competitive haptens, we designed haptens that should have relatively lower affinity compared to the target analyte to improve the sensitivity of the assay. Second, we took advantage of the strengths of using the hapten−protein-coated format. Advantages of this format include using rabbit antibody sparingly compared to the antibody-coated format that generally used 10 to 100 times more antibody reagent. Hapten, which can be costly to synthesize, is also used more sparingly in this format because hapten−protein conjugates as coating antigens are generally more stable than hapten−enzyme conjugates that require the preservation of the enzymatic activity to be functional.
Immunoassays for TCS detection have been developed previously. 18, 19 However, the formats in which these have been developed require a relatively large amount of primary antibody reagent because the solid support (e.g., magnetic beads or microtiter plate) is coated with primary antibody. Because polyclonal antibody reagents are typically only generated once from a single animal, their supply is limited, thus not permitting its use for analyzing large sample sets without the potential need to reoptimize another aliquot of reagent. An ELISA format in which a labeled secondary antibody is used would permit a more sparing use of primary antibody while using a hapten−protein conjugate as the immobilized coating antigen, thereby extending the usefulness of the assay.
This study reports the preparation of novel haptens, characterization of newly generated antibodies, immunoassay optimization, and validation. This is the first report on the analysis of biosolids by immunoassay. Furthermore, the reagents generated may be further applied to immunosensorbased assays and used in the generation of antibodies from new sources, such as camelid-derived VHH nanobodies, which are ongoing projects in this laboratory.
■ EXPERIMENTAL SECTION
Chemicals and Instruments. All hapten coupling reagents (sulfo-N-hydroxysuccinimide, N-hydroxysuccinimide, 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide, dicyclohexylcarbodiimide, isobutyl chloroformate, tri-n-butylamine), bovine serum albumin (BSA), thyroglobulin (Tg), goat antirabbit IgG peroxidase conjugate (GAR-HRP), Tween 20, and 3,3′,5,5′-tetramethylbenzidine (TMB) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO). ELISA was performed on 96-well microtiter plates (Nunc MaxiSorp, Roskilde, Denmark) and read spectrophotometrically with a microplate reader (Molecular Devices, Sunnyvale, CA) in dual-wavelength mode (450 and 650 nm).
Hapten Synthesis. Due to their molecular size, TCS haptens require conjugation to carrier proteins to be immunogenic. Thus, TCS haptens containing a carboxylic group or an amino group were designed and synthesized ( Figure 1 ). The −NH 2 or −COOH linker was introduced at the 4-Cl (hapten T2 or T3) position in the TCS molecule to keep the −OH group free and most distal to the point of attachment to the protein. To retain the −OH group, we protected it during synthesis of the haptens and then deprotected it using boron tribromide. When coupled to the carrier protein, these haptens fully presented the majority of the TCS molecule for antibody recognition resulting in an antibody selective for TCS.
Hapten precursors described in the Supporting Information were initially synthesized with a nitroaromatic (4; Scheme 2) or aldehyde (7, Scheme 3 ) analog prepared from commercially available starting materials via nucleophilic aromatic substitution. Compound 4 was hydrogenated to provide the aniline (5, Scheme 2 ), followed by boron tribromide-mediated cleavage of the methyl ester to obtain the immunizing hapten T2 that was conjugated to protein by the diazotization method.
An unsaturated spacer was introduced into methylated dichlorophenoxybenzaldehyde (7) by enylation with phosphonoacetate or phosphonocrotonate using lithium hydroxide and molecular sieve by the Wittig or Horner−Wadsworth− Emmons reaction 20 to synthesize the intermediates 8, 18, or 20 (Schemes 3, 8, or 9, respectively). To produce hapten T3, we converted the unsaturated spacer in intermediate 8 to a saturated spacer (9) by using Pd/C under H 2 atmosphere. Cleavage of the aryl ether (Ar−OCH 3 ) and the ester by boron tribromide provided a strategy for the unmasking of both the ArOH and ArCO 2 H functional groups. 21 For coating hapten T7, compound 8 was not converted to a saturated spacer. A similar strategy was used for coating haptens T8 and T9 ( Figure 1 ) using compounds 18 and 20 with unsaturated linkers. All four haptens were coupled to proteins using the Nhydroxysuccinimide method. 22 The haptens T1 and T5 described in Schemes 1 and 5 were alkylated to obtain different lengths of a single-bonded hydrocarbon linker at the 2′-OH position of the TCS molecule. Ethyl bromobutyrate or ethyl bromohexanoate was used for the carbon linker attachment on the TCS structure. More detailed synthetic procedures are provided in the Supporting Information.
Preparation of Immunogen and Coating Antigens. For haptens containing a −COOH group, conjugation to proteins was made using the N-hydroxysuccinimide (NHS), 22 sulfo-NHS carbodiimide, 22 or mixed anhydride method. 23 Haptens containing an −NH 2 group were conjugated by a diazotization method. 22 Haptens T1, T2, and T3 ( Figure 1 ) conjugated to Tg were used as immunogens. Haptens T1−T9 were conjugated to bovine serum albumin (BSA) for use as coating antigens. Further hapten−protein conjugation details can be found in the Supporting Information.
Immunization and Antiserum Preparation. The immunization was performed according to the procedure reported previously. 24 For each immunogen, three female New Zealand white rabbits were immunized (rabbits 1288, 1289, and 1290 against hapten T1−Tg, rabbits 1154, 1155, and 1156 against hapten T2−Tg, and rabbits 1157, 1158, and 1159 against hapten T3−Tg). After seven boosts, a final serum was collected about 5 months following the first immunization. Antiserum was obtained by centrifugation, stored at −20°C, and used without purification.
Immunoassay. The ELISA was performed according to the procedure described previously. 24 In this format, the hapten− protein conjugate is coated to the well of the microtiter plate. After incubation with analyte and primary antibody, unbound primary antibody is washed away. The remaining primary antibody is detected using a secondary antibody that is conjugated to an enzyme. The IC 50 value, an expression of the sensitivity of the immunoassay, and the limit of detection (LOD), defined as the IC 10 value, were obtained from a fourparameter logistic equation. Borosilicate glass tubes were used to prepare standard and sample solutions.
Cross-reactivity. The cross-reactivity studies were evaluated using compounds that are structurally similar to TCS. The cross-reactivity was calculated as the (IC 50 of the target analyte/IC 50 of the tested compound) × 100.
Preparation of Water Samples. Water samples used for TCS analysis were taken from a fish exposure study representative of U.S. Environmental Protection Agency (USEPA) standard exposure procedures. 25 Water samples used in the fish exposure study were prepared using a single batch of deionized water adjusted to USEPA moderately hard standards (pH 7.4−7.8; hardness 80−100 mg/L; alkalinity 57− 64 mg/L). 26 Aliquots of the adjusted water were added to beakers and then spiked with 100 μL of concentrated stock solutions of TCS in methanol to obtain TCS concentrations of 0−300 μg/L with a final concentration of 0.01% methanol. Aliquots from each beaker were taken for analysis prior to the addition of fish. For analysis, water samples were diluted 5−25 times with 10% methanol in phosphate-buffered saline (PBS) buffer to bring the absorbance values within the linear range for immunoassay. For LC−MS/MS analysis, water samples were extracted in triplicate by solid-phase extraction (SPE) as detailed in the Supporting Information.
Analysis of Biosolid Samples. Biosolid samples were collected from a regional wastewater-treatment plant that processes about 140 million gallons of wastewater daily. At the time of sample collection, this facility diverted about 20% of the total sewage sludge to the production of biosolids for use as fertilizer, while the remainder was disposed into unlined dedicated land disposal areas. Samples were obtained from the dedicated land disposal area and were not further characterized. The samples were prepared according to the method of Ogunyoku and Young. 27 Briefly, samples were dried at 70°C for 24 h and homogenized with a mortar and pestle. For analysis by immunoassay, 15 mL of a mixture of methanol and acetone (1:1, v/v) were added to 1 g of dried sample. The mixture was shaken for 24 h at 210 rpm at 60°C and centrifuged for 30 min at 4000 rpm. The extract was further diluted 375−3000 times with 10% methanol in PBS buffer prior to the immunoassay. For LC−-MS/MS analysis, the dried biosolid samples (1.0 g) were extracted with methanol using a reflux apparatus. The extract was purified by SPE prior to using the LC−MS/MS analysis method of Ogunyoku and Young. 27 (see the Supporting Information for details).
■ RESULTS AND DISCUSSION
Hapten Synthesis. Novel immunizing haptens that mimic the whole TCS molecule were designed and synthesized ( Figure 1 ). Other researchers have designed haptens that linked the TCS molecule to carrier proteins through the 2′-OH group. 28 Our design focused on utilizing linkers that allowed the 2′-OH group to remain free, as it is in the parent compound, because the 2′-OH is one element that distinguishes TCS from other diphenyl ethers. Another study explored using haptens that mimic only part of the TCS molecule but found that titers were low to these fragmentary haptens. 19 Although we and others have utilized this fragmentary strategy successfully for polybrominated diphenyl ethers and polychlorinated biphenyls, 14, 29 for this study we focused on haptens that mimic the whole molecule for immunization.
In a competitive ELISA, reducing the apparent affinity of the antibody for the coating antigen relative to its affinity for TCS usually results in more sensitive assays. Our coating hapten design utilized several strategies for achieving this goal. For example, haptens T7, T8, and T9 contain linkers that are unsaturated, and immunizing haptens contained linkers that were saturated. All coating haptens contained substitutions at the 2′-OH position, while immunizing haptens retained the 2′-OH. Linkers were attached at the 2′-or 4′-positions in coating haptens but were in the 4-position for immunizing haptens. Finally, haptens where the 2′-OH was substituted with Cl or Br were also synthesized. Such changes in linker composition, linker location, and substitutions at key positions provide a library of coating antigens that can greatly improve the chances of developing a highly sensitive and selective immunoassay. 30−32 The structural characterization of all haptens is provided in the Supporting Information.
Antibody Characterization. The titer of the antisera collected after each boost was determined by the homologous indirect ELISA. All of the antisera showed relatively high constant titers after the fifth immunization and no significant affinity for BSA alone. All nine antisera were then screened for inhibition against all coating antigens at two concentrations (5 and 500 μg/L) of TCS. Antisera/coating antigen combinations that showed over 50% inhibition at 500 μg/L and over 20% inhibition at 5 μg/L were rescreened at 10 concentrations of TCS ranging from 0.003 to 5000 μg/L.
All antisera−coating antigen combinations that were homologous assays had IC 50 values above 750 μg/L or, in the case of antiserum no. 1156, exhibited low binding, as demonstrated by the low A max . Among the heterologous antisera−coating antigen assays, those utilizing antisera against hapten T1 (no. 1288) or T3 (no. 1158) had higher IC 50 values, while antiserum against hapten T2 (no. 1155 and no. 1156) had mixed results depending upon the coating antigen used ( Table 1 ). The assay demonstrating the lowest IC 50 used antiserum no. 1155 that was raised against immunizing hapten T2 and coating antigen T8-BSA. Similar to the results from Brun and colleagues, 19 the best immunogen identified was one that contained a nitrogen as the first atom on the linking arm.
Haptens B1 and B2 that replace chlorine substituents of TCS hapten T8 by bromine atoms were synthesized to develop a BDE immunoassay ( Figure 1 ). 14 These haptens were screened to introduce additional heterology in the coating antigen. A similar strategy was used for an earlier TCS assay 28 and for an assay for deltamethrin. 33 For antiserum no. 1288 (raised against T1-Tg) and antiserum no. 1158 (raised against T3-Tg), the use of B1-BSA resulted in improved sensitivity compared to the best TCS-based coating antigen for each antibody. For antiserum no. 1155, both B1-and B2-BSA resulted in sensitive assays but were not superior to assays utilizing TCS haptens T8 and T9. Among the combinations of B1-BSA−antiserum no. 1288, B1-BSA−antiserum no. 1158, and B1-BSA−antiserum no. 1155, the latter was selected as one of the assays used in further assay development because it had the lowest overall IC 50 among the assays utilizing brominated coating antigens (Table 1) .
Unique coating haptens in which the hydroxyl group was replaced by a Cl atom (haptens T6, T8, and T9) for the heterologous competition format resulted in remarkably increased assay sensitivity. Although the antibody (no. 1155) bound these coating haptens with moderate affinity, the affinity for free TCS was greater, allowing the displacement of the antibody by low concentrations of TCS resulting in a sensitive assay. Conversely, the assay that used hapten T7 that contained a −OCH 3 group in place of the −OH was not sensitive, indicating that the affinity of the antibody for the −OCH 3 group was greater than for the −OH. In conclusion, the coating antigen, hapten T9-BSA (where the hydroxyl group was replaced by a Cl atom and a medium-length rigid carbon linker was included), along with antibody no. 1155, was selected for further assay development due to its high maximum signal, high signal-to-noise ratio, steep slope, and low IC 50 value.
Optimization. Utilizing immunizing haptens T1 and T2 resulted in reasonable antibody affinity to the target analyte in a competitive assay format and rabbit antiserum no. 1155 generated against T2 provided the lowest IC 50 (Table 1) . Hapten T9-BSA and antiserum no. 1155 was found to be the best combination and was used for these optimization studies. Methanol (MeOH) is generally used as a cosolvent in the assay buffer (PBS) to ensure the solubility of lipophilic analytes. As seen in Table 2 , because lower amounts of MeOH provided better sensitivity, 10% MeOH was selected for the further assay development. The IC 50 was not significantly affected by pH values ranging from 5.5 to 8.5 in the buffer, but the maximum absorbance signals varied. A pH 8.5 PBS assay buffer containing 10% MeOH was selected for further experiments because the assay had the lowest IC 50 and a good ratio of maximum to minimum signal (A/D) of 16. Because the maximum absorbance signals are generally significantly reduced by higher ionic strength (2× or 4× PBS) due to the suppression of the binding interaction of antibody to antigen, 1× PBS (0.15 M) was used for the assay.
The final assay conditions were as follows: Primary antiserum no. 1155 was diluted in PBST (PBS containing 0.05% Tween 20). The optimized ELISA used a coating antigen of T9-BSA at a concentration of 1 μg/mL and antiserum no. 1155 produced against hapten T2-Tg at a dilution of 1/5000 in PBST before the competition. The plate coated with the coating antigen was blocked with 0.5% BSA. The assay buffer was 10% MeOH in 0.15 M PBS, pH 8.5. Under these conditions, the assay had a linear range (IC 20−80 ) of 0.2−6.7 μg/L of the target and an IC 50 value of 1.2 μg/L. The LOD in buffer was 0.1 μg/L, the IC 10 value (Figure 2 ). This assay is comparable in sensitivity to the formats reported earlier that exhibited IC 50 values for TCS of 3.85 19 and 0.25 μg/L 18 Cross-reactivity. TCS metabolites and its structural analogs were evaluated for cross-reactivity. The assay was selective for the target analyte TCS. Cross-reactivities to methyl TCS (2,4,4′-trichloro-2′-methoxydiphenyl ether) and BDE-47 (2,2′,4,4′-tetrabromodiphenyl ether) were 3 and 4%, respectively, while the antimicrobial triclocarban and two thyroid hormones cross-reacted <1% ( Table 3) . These cross-reactivity patterns are very similar to the assay described by Brun et al., 19 and the assay by Shelver 18 cross-reacted with methyl-TCS (312%) and BDE congeners (2.5−64%). It is likely that both the phenyl and hydroxyl are important for binding by the antibody that was generated against immunizing hapten T2, where the −OH was exposed, and explains the similar findings by Brun et al. in which the phenyl and hydroxyl are also exposed. 19 The antibody generated against hapten T1, where the −OH group of TCS was alkylated to −OCH 2 (CH 2 ) 2 − COOH, highly recognized methyl TCS and BDE-47, and showed less specificity to TCS due to the lack of H-bonding donation, which is consistent with earlier findings using a similar immunizing hapten conjugated through the hydroxyl. 18 Analysis of Fish Exposure and Biosolid Samples. Water samples that were used to test the toxicity of TCS to fish were diluted 5-fold at low concentrations and 25-fold at high concentrations prior to the immunoassay to bring the samples into the linear range of the assay. Recoveries of 85−92% were obtained from both the immunoassay and LC−MS/MS analysis. The recoveries obtained using the immunoassay method are comparable to other studies in which fortified mineral and wastewater samples were analyzed without cleanup, 18, 19 having reported recoveries ranging from 75 to 113%. Similarly, recoveries above 85% were reported for LC− MS/MS methods that utilized solid-phase extraction. 34, 35 An average ratio between instrumental analysis and immunoassay results was less than 1.2 ( Table 4) .
Analysis of biosolid samples can be challenging because of the complexity of the samples; thus, multistep sample extraction and cleanup methods are necessary, 36 using techniques such as accelerated solvent extraction coupled to solid-phase cleanup. 37 Immunoassays are often advantageous because the antibody provides some selectivity for the analyte in the presence of matrix, eliminating the need for exhaustive cleanup before analysis. 38 Our goal was to use a simple, field-portable sample preparation method; thus, samples were extracted with methanol−acetone and shaking. For instrumental analysis, the samples were extracted using a methanol reflux method described in the Supporting Information. The LC− MS/MS extraction and analysis showed higher levels of TCS than the ELISA method. Because the sample preparation methods were not identical, it is not known whether the difference is due to extraction efficiency or a matrix effect on either or both detection methods. Nevertheless, the concentrations of TCS found in these biosolid samples were within the wide range of TCS concentrations found in other biosolids. 39 The average ratio between the results of both methods was less than 1.6 ( Table 5 ), indicating that this immunoassay is suitable for the determination of TCS in biosolid samples as an alarm or primary screening method.
In conclusion, for the development of a sensitive and selective immunoassay for TCS, a hapten preserving the 2′-OH group in a near-perfect molecular mimic of TCS aids in the selective recognition of the TCS by the resulting antibody. A unique feature of this immunoassay is the use of a novel heterologous coating hapten, where the −OH was substituted with a −Cl. This resulted in a decreased affinity of the antibody for the coating antigen and subsequently increased the ability of the analyte to compete resulting in the highest sensitivity assay. This immunoassay was more sensitive (IC 50 value of 1.2 μg/L) compared to the TCS assay developed by Brun et al. (3. 85 μg/ L) 19 but less sensitive than the existing Abraxis assay kit for TCS (0.25 μg/L, http://www.abraxiskits.com). Moreover, this immunoassay utilizes less primary antibody than the previously described assays. 18, 19 Furthermore, the results from this assay were in agreement with the LC−MS/MS method for testing Samples containing spiked concentrations of 0−3 μg/L were diluted five times in the assay buffer prior to analysis; samples containing 100−300 μg/L were diluted 25 times in the assay buffer. 
S-1

Immunizing haptens
Synthesis of 4-(5-chloro-2-(2,4-dichlorophenoxy)phenoxy)butanoic acid (Hapten T1, BDH 382-02, Scheme 1):
The mixture of triclosan (400 mg, 1.38 mmol), 4-bromo-butyric acid tert-butyl ester (399 mg, 1.79 mmol), and potassium carbonate (286 mg, 2.07 mmol) in 2 mL of anhydrous DMF was reacted at 100 o C for 3 h. The resulting mixture was filtered to remove excess K 2 CO 3 and HBr generated in the reaction. The filtrate diluted with 20 mL of ethyl acetate was washed twice with 20 mL of distilled water. The organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation. The residue was chromatographed on silica gel eluting with a mixture of ethyl acetate/hexane (1:2, v/v). Fractions containing pure product by TLC were stripped under high vacuum to obtain 179 mg of Compound 2 (BDH 382-01) as a transparent oil. TLC (ethyl acetate/hexane=1:10, v/v) R f , 0.54.
Trifluoroacetic acid (TFA) (0.5 mL) was added to the ester intermediate (BDH 382-01) and the mixture was allowed to stand at ambient temperature for 30 min. After the addition of 50 mL of distilled water and acidification with 6 N HCl to pH 2, the mixture was extracted twice with 50 mL of ethyl acetate. The combined organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by rotary evaporation. The concentrate was recrystallized from a mixture of ethyl acetate and hexane to give Hapten T1 (391 mg, yield: 62%) as a white solid: mp 85- 
S-3
Synthesis of 2-(4-amino-2-chlorophenoxy)-5-chlorophenol (Hapten T2, BDH 382-42, Scheme 2):
This hapten was synthesized according to the method described (Freundlich et al. 2005) . To a solution of 4chloro-2-methoxyphenol (1085 mg, 6.84 mmol), suspended K 2 CO 3 (945 mg, 6.84 mmol) in dimethylformamide (DMF, 5 mL) was added 3-chloro-4-fluoronitrobenzene (1000 mg, 5.7 mmol). The reaction mixture was refluxed overnight. The mixture was diluted with ethyl acetate (200 mL) and 1 N NaOH (200 mL). The organic layer was separated, washed with water (100 mL), and concentrated. The residue was recrystallized from a mixture of ethyl acetate and hexane to give a white solid, Compound 4 (BDH-382-26) (1539 mg, yield 86%). 1 The mixture of Compound 4 (500 mg, 1.60 mmol) and stannous chloride dihydrate (3610 mg, 16 mmol) in 10 mL of ethanol was stirred at 70 °C in an oil bath for 1 h and at room temperature for 2 h. The mixture was cooled and poured into the slurry of water, ethyl acetate, and Celite. NaHCO 3 was added in portions. The neutral mixture was filtered, and the solids on the filter and in the flask were washed with water and ethyl acetate. The ethyl acetate phase was separated and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure. The oil residue was purified by using silica gel chromatography with a mixture of methanol/methylene chloride 
S-4
Synthesis of 3-(3-chloro-4-(4-chloro-2-hydroxyphenoxy)phenyl)propanoic acid (Hapten T3, BDH 382-48, Scheme 3):
3-Chloro-4-(4-chloro-2-methoxyphenoxy)benzaldehyde (Compound 7, BDH-382-44) was synthesized according to the method described ) using 3-chloro-4-fluorobenzdehyde (1000 mg, 6.3 mmol) and 4-chloro-2-methoxyphenol (999 mg, 6.3 mmol). 1 To a solution of Compound 7 (500 mg, 1.69 mmol) and triethyl 4-phosphonoacetate (417 mg, 1.86 mmol) in dry tetrahydrofuran (THF, 10 mL) was added LiOH . H 2 O (78 mg, 1.86 mmol) and molecular sieve 4 Å (2.5 g). The mixture was refluxed overnight under N 2 conditions. Ethyl acetate (50 mL), water (50 mL) and NaCl (1 g) were added and the organic layer was separated. After removing the organic solvent, the crude residue was purified by silica gel chromatography using a mixture of ethyl acetate and hexane To a cooled solution of Compound 9 (50 mg, 0.13 mmol) in CH 2 Cl 2 was added a 1 M solution of BBr 3 in CH 2 Cl 2 (0.26 mL, 0.26 mmol). After stirring at 0 o C for 4 h, an additional 2 mL BBr 3 in CH 2 Cl 2 was added. The reaction mixture was stirred for another 30 min and then water (50 mL) and 1 N NaOH (3 mL) were added. The mixture was diluted with ethyl acetate (twice, 50 mL) and water (50 mL). The organic layers were separated, combined, and concentrated. The crude residue was recrystallized from a mixture of ethyl acetate and hexane to give a white solid of Compound 10 (BDH 382-48) ( 
S-5
Coating haptens
Synthesis of 2-(5-chloro-2-(2,4-dichlorophenoxy)phenoxy)acetic acid (Hapten T4, BDH 382-16, Scheme 4):
Compound 11 (BDH 382-15) was synthesized using tert-butyl bromoacetate using the same synthetic method as Compound 3. That is, the mixture of triclosan (400 mg, 1.38 mmol), tert-butyl bromoacetate (349 mg, 1.79 mmol), and potassium carbonate (286 mg, 2.07 mmol) in 2 mL of anhydrous DMF was reacted at 100 o C for 3 h. The resulting mixture was filtered to remove excess K 2 CO 3 and HBr produced in the reaction. The filtrate, diluted with 20 mL of ethyl acetate was washed twice with 20 mL of distilled water. The organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by evaporation. The residue was chromatographed on silica gel eluting with the mixture of ethyl acetate/hexane (1:2, v/v). Fractions containing pure product by TLC were stripped under high vacuum to obtain Compound 11 as a transparent oil. TLC (ethyl acetate/hexane=1:10, v/v) R f , 0.47.
Trifluoroacetic acid (TFA) (0.5 mL) was added to the ester intermediate (Compound 11) and the mixture was allowed to stand at ambient temperature for 30 min. After the addition of 50 mL of distilled water and acidification with 6 N HCl to pH 2, the mixture was extracted twice with 50 mL of ethyl acetate. The combined organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by evaporation. 6-(5-chloro-2-(2,4-dichlorophenoxy)phenoxy)hexanoic acid (Hapten T5, BDH 382-17, Scheme 5) :
Scheme 4
Synthesis of
The mixture of triclosan (824 mg, 2.76 mmol), ethyl bromohexanoate (800 mg, 3.58 mmol), and potassium carbonate (572 mg, 4.14 mmol) in 2 mL of anhydrous DMF was reacted at 100 o C overnight. The resulting mixture was filtered to remove excess K 2 CO 3 and HBr produced in the reaction. The filtrate diluted with 20 mL of ethyl acetate was washed twice with 20 mL of distilled water. The organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by evaporation. The residue was chromatographed on silica gel eluting with the mixture of ethyl acetate/hexane (1:2, v/v). Fractions containing pure product by TLC were stripped under high vacuum to the bromoester as a transparent oil. TLC (ethyl acetate/hexane, 1:10, v/v) R f , 0.75. 6N NaOH (5 mL) and methanol (10 mL) was added to the ester intermediate and the mixture was allowed to stand at 70 o C for 2 d. After the addition of 50 mL of distilled water and acidification with 6 N HCl to pH 2, the mixture was extracted twice with 50 mL of ethyl acetate. The combined organic layer was dried over anhydrous sodium sulfate, and the solvent was removed by evaporation. The concentrate was recrystallized from a mixture of ethyl acetate and hexane to give Hapten T5 (1022 mg, yield: 92%) as a white solid. TLC (methylene S-6 chloride/MeOH/acetic acid=2:18:0.02, v/v/v) R f , 0.54. 1 H NMR (300 MHz, chloroform-d) δ 7.42 (d, J = 2.5 Hz, 1H), 7.09 (dd, J = 2.5, 0.9 Hz, 1H), 7.06 (dd, J = 2.5, 0.9 Hz, 1H), 6.96 -6.95 (m, 1H), 6.94 (s, 4H), 6.93 (d, J = 1.0 Hz, 1H), 3.91 (t, J = 6.1 Hz, 4H), 2.29 (t, J = 7.4 Hz, 3H), 1.61 (dp, J = 22.8, 7.7, 7.1 Hz, 10H), 1.28 (q, J = 7.0, 5.6 Hz, 4H). T7, BDH-382-68 of (2E,4E)-5-(3-chloro-4-(2,4-dichlorophenoxy) 
Cl
Synthesis of (E)-3-(4-(2,4-dichlorophenoxy)-3-methoxyphenyl)acrylic acid (Hapten
Synthesis of (E)-3-(3-chloro-4-(2,4-dichlorophenoxy)phenyl)-2-methylacrylic acid (Hapten T9, BDH 382-71, Scheme 9):
A suspension of the aldehyde (Compound 15, 500 mg, 1.67 mmol), triethyl 2-phosphonopropionate (438 mg, 1.84 mmol), LiOH . H 2 O (77 mg, 1.84 mmol) and activated 4 Å molecular sieve (2.76 g) in tetrahydrofuran and under a stream of nitrogen gas was refluxed overnight. The crude reaction mixture was filtered through silica gel, eluting with ethyl acetate. The mixture was concentrated. The residue was purified with silica gel using a mixture
